| D2 | Scale-up of multi-month dispensation of antiretroviral therapy among children living with HIV as a COVID-19 mitigation measure and retention strategy, Zambia, 2020 | E-poster | Impact evaluation of differentiated service delivery |
| D2 | An evaluation of nurse-led Community ART Distribution (CAD) for stable ART clients in Malawi | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Impact of a family-centered care model on viral suppression among HIV-infected children in Migori, Kenya | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Clinical outcomes of community ART distribution: DRC's experience with the PODI+ model | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Cost-effectiveness of community delivery of HIV care in South Africa | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Does onsite HIV self-testing enhance linkage to care? A case study of HIVST Challenge Fund Project in Kenya | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Optimizing transitioning to differentiated service delivery key approach to achieving (UNAIDS) 90-90-90 treatment targets in Kogi State, Nigeria | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Differentiated prevention testing and art delivery for modified general populations and key populations in Nigeria: a documentation of best practice models | E-poster | Impact evaluation of differentiated service delivery |
| D3 | Trust in the PrEP provider is associated with accurate self-reported PrEP adherence among adolescent girls and young women in sub-Saharan Africa | E-poster | Provider and facility determinants of outcomes |
| D3 | Comparison of anti-retroviral treatment (ART) failure by health-facility level prior to widespread availability of laboratory-based monitoring in east Zimbabwe | E-poster | Provider and facility determinants of outcomes |